Tuesday, June 1, 2021

BIIB: Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemra® (Tocilizumab)...

New alert via PocketInfo for BIIB:

Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemra® (Tocilizumab)...

Press Releases: http://www.biogenidec.com/press_releases.aspx?ID=5980
SEC Filings: http://www.biogenidec.com/sec_filings.aspx?ID=5916
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8

No comments:

Post a Comment